DataMEDS AI, Inc. — Company profile
Healthcare · Pharmaceutical Retailers · United States
Last price 1.92 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Details
| Name | DataMEDS AI, Inc. |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Founded | 2022 |
| Ipo Date | 2025-02-21 |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US9495032057 |
| Cusip | 949503205 |
| Cik | 0002030763 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Gerald E. Commissiong | Interim Co-Chief Executive Officer |
| Prashant Patel M.Sc., R.Ph. | Interim Co-Chief Executive Officer, President and Director |
| Brett Thompson | Chief Technology Officer |
Contact
| Address | 3000 Bayport Drive, Suite 950, Tampa, Florida 33607, United States |
| Phone | 844 203 6092 |
| Website | https://datamedsai.com |